{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-099101","form_type":"8-K","ticker":"GILD","cik":"0000882095","company_name":"GILEAD SCIENCES, INC.","filed_at":"2022-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.416487+00:00","generated_at":"2026-06-23T11:37:12.467068+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Gilead settles patent litigation for Descovy, Vemlidy, Odefsey; generic licenses begin 2031-2032","bullets":["Agreements with Lupin, Apotex, Macleods, Hetero, Cipla resolve patent challenges for HIV drugs.","License for Descovy and Vemlidy begins Oct 31, 2031; for Odefsey begins Jan 31, 2032, with earlier entry possible.","Agreements filed with FTC and DOJ; dismissals filed in Delaware district court.","Settlement removes litigation uncertainty but establishes generic entry timeline for key HIV portfolio."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-099101","json":"https://secwatch.observer/filing/0001104659-22-099101.json","markdown":"https://secwatch.observer/filing/0001104659-22-099101.md","text":"https://secwatch.observer/filing/0001104659-22-099101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882095/000110465922099101/0001104659-22-099101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882095/000110465922099101/tm2225634d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T11:37:12.467068+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}